Diagnostic Algorithm in Suspected Upper Extremity Deep Vein Thrombosis

NCT ID: NCT01324037

Last Updated: 2014-12-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

406 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-03-31

Study Completion Date

2013-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Deep vein thrombosis (DVT) of the arm, officially called upper extremity DVT is a rare disorder and accounts for up to 1-4% of all cases of deep vein thrombosis. In case of a thrombosis, there is a blood clot in one of the veins, which should be treated with blood thinners (anticoagulants). The aim of the present study is to see whether it is safe to use a combination of tests for the diagnosis of arm thrombosis. In all patients, we will use a clinical decision rule (clinical judgement) and a laboratory test (D-dimer testing), in most patients also an ultrasound of the arm will be done. The combination of these tests was found to be safe and effective in patients with thrombosis of the legs.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Consecutive patients with clinically suspected upper extremity deep vein thrombosis (UEDVT) are potentially eligible for the study. Patients will be categorized as likely or unlikely to have UEDVT based on a clinical decision rule (CDR). Patients "unlikely" for UEDVT based on the CDR and with normal D-dimer levels will not receive anticoagulant treatment and will be followed-up for 3 months. All patients with a likely CDR or patients with an unlikely CDR combined with elevated D-dimer levels will undergo ultrasonography. In case of an indeterminate ultrasonography result, ultrasonography testing will be repeated 3-5 days later. The same applies for patients with a negative ultrasound and the combination of a high probability and elevated D-dimer levels. Anticoagulants will be withheld in all patients for whom UEDVT will be excluded by the initial diagnostic work-up.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Suspected Upper Extremity Deep Vein Thrombosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

clinically suspected upper extremity deep vein thrombosis

Patients with suspected upper extremity DVT

Group Type EXPERIMENTAL

diagnostic algorithm

Intervention Type OTHER

diagnostic algorithm consisting of a clinical decision rule, D-dimer and (serial) ultrasonography

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

diagnostic algorithm

diagnostic algorithm consisting of a clinical decision rule, D-dimer and (serial) ultrasonography

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients from the emergency department, in and out patient clinic with clinically suspected upper extremity deep vein thrombosis

Exclusion Criteria

* No informed consent obtained
* Legal age limitation (country specific)
* Use of anticoagulants in therapeutic dosages longer than 24 hours prior to randomisation
* Prior vein thrombosis in the same arm
* Life expectancy \< 3 months
* Haemodynamic instability
* Previous participation in the study
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Medical Center Groningen

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Pieter W. Kamphuisen, MD PhD

MD PhD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Pieter Willem Kamphuisen, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Veterans Affairs Hospital

Washington D.C., District of Columbia, United States

Site Status

Medical University Graz

Graz, , Austria

Site Status

Medical University Innsbruck

Innsbruck, , Austria

Site Status

University Hospital Leuven

Leuven, , Belgium

Site Status

University Hospital Dresden

Dresden, , Germany

Site Status

Ospedali Riuniti

Bergamo, , Italy

Site Status

University Hospital Bologna

Bologna, , Italy

Site Status

Hospital D'Annunziata

Chieti, , Italy

Site Status

University Hospital of Padova

Padua, , Italy

Site Status

Servizio Sanitario Regionale Emilia - Romagna

Reggio Emilia, , Italy

Site Status

Rijnstate Hospital

Arnhem, Gelderland, Netherlands

Site Status

Onze Lieve Vrouwe Gasthuis

Amsterdam, , Netherlands

Site Status

Slotervaart Hospital

Amsterdam, , Netherlands

Site Status

Maxima Medisch Centrum

Eindhoven/Veldhoven, , Netherlands

Site Status

University Medical Center Groningen

Groningen, , Netherlands

Site Status

Academic Hospital Maastricht

Maastricht, , Netherlands

Site Status

Antonius Hospital

Nieuwegein, , Netherlands

Site Status

Geneva University Hospital

Geneva, , Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Austria Belgium Germany Italy Netherlands Switzerland

References

Explore related publications, articles, or registry entries linked to this study.

Constans J, Salmi LR, Sevestre-Pietri MA, Perusat S, Nguon M, Degeilh M, Labarere J, Gattolliat O, Boulon C, Laroche JP, Le Roux P, Pichot O, Quere I, Conri C, Bosson JL. A clinical prediction score for upper extremity deep venous thrombosis. Thromb Haemost. 2008 Jan;99(1):202-7. doi: 10.1160/TH07-08-0485.

Reference Type BACKGROUND
PMID: 18217155 (View on PubMed)

Bernardi E, Pesavento R, Prandoni P. Upper extremity deep venous thrombosis. Semin Thromb Hemost. 2006 Oct;32(7):729-36. doi: 10.1055/s-2006-951458.

Reference Type BACKGROUND
PMID: 17024601 (View on PubMed)

Baarslag HJ, van Beek EJ, Koopman MM, Reekers JA. Prospective study of color duplex ultrasonography compared with contrast venography in patients suspected of having deep venous thrombosis of the upper extremities. Ann Intern Med. 2002 Jun 18;136(12):865-72. doi: 10.7326/0003-4819-136-12-200206180-00007.

Reference Type BACKGROUND
PMID: 12069560 (View on PubMed)

Di Nisio M, Van Sluis GL, Bossuyt PM, Buller HR, Porreca E, Rutjes AW. Accuracy of diagnostic tests for clinically suspected upper extremity deep vein thrombosis: a systematic review. J Thromb Haemost. 2010 Apr;8(4):684-92. doi: 10.1111/j.1538-7836.2010.03771.x. Epub 2010 Feb 6.

Reference Type BACKGROUND
PMID: 20141579 (View on PubMed)

Kleinjan A, Di Nisio M, Beyer-Westendorf J, Camporese G, Cosmi B, Ghirarduzzi A, Kamphuisen PW, Otten HM, Porreca E, Aggarwal A, Brodmann M, Guglielmi MD, Iotti M, Kaasjager K, Kamvissi V, Lerede T, Marschang P, Meijer K, Palareti G, Rickles FR, Righini M, Rutjes AW, Tonello C, Verhamme P, Werth S, van Wissen S, Buller HR. Safety and feasibility of a diagnostic algorithm combining clinical probability, d-dimer testing, and ultrasonography for suspected upper extremity deep venous thrombosis: a prospective management study. Ann Intern Med. 2014 Apr 1;160(7):451-7. doi: 10.7326/M13-2056.

Reference Type DERIVED
PMID: 24687068 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NL29834.018.09

Identifier Type: -

Identifier Source: org_study_id